Article
Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.
Current HIV research - 1 Apr 2010
Taiwo Babafemi, Chaplin Beth, Penugonda Sudhir, Meloni Seema, Akanmu Sulaimon, Gashau Wadzani, Idoko John, Adewole Isaac, Murphy Robert, Kanki Phyllis
Abstract excerpt
OBJECTIVE: The primary objective of this study was to estimate etravirine activity in a cohort of patients infected with non-B subtype HIV-1 and failing nevirapine-based therapy. MATERIALS AND METHODS: Genotypic resistance testing was performed if viral load was >OR= 1,000 copies/ml after receivi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
